| Literature DB >> 27514644 |
Chunshuai Wu1,2, Jiajia Chen1, Yonghua Liu2, Jinlong Zhang1, Wensen Ding2, Song Wang1,2, Guofeng Bao1, Guanhua Xu1, Yuyu Sun1, Lingling Wang1, Limin Chen1, Haiyan Gu1, Baihong Cui1, Zhiming Cui3,4.
Abstract
Spinal cord injury (SCI) is one of the most common and severe complications in spine injury. It is difficult to prevent cell necroptosis and promote the survival of residual neurons after SCI. Proteasome beta-4 subunit (PSMB4) is the first proteasomal subunit with oncogenic properties promoting cancer cell survival and tumor growth in vivo, and our previous study showed that PSMB4 is significantly associated with neuronal apoptosis in neuroinflammation. However, PSMB4 function in the necroptosis after SCI is unkown. RIP3, a key regulatory factor of necroptosis, correlates with the induction of necroptosis in various types of cells and signaling pathway. Upregulation of the RIP3 expression may play a role as a novel molecular mechanism in secondary neural tissue damage following SCI. In this study, we established an acute spinal cord contusion injury model in adult rats to investigate the potential role of PSMB4 during the pathological process of SCI. We found PSMB4 expression was significantly up-regulated 3 days after injury by western blot and immunohistochemical staining. Double immunofluorescent staining indicated obvious changes of PSMB4 expression occurred in neurons. Significant up-regulation of PSMB4 expression was observed in Rip3 positive neurons at 3 days after SCI, which indicated that PSMB4 might play a vital role in the regulation of Rip3. Overexpress and knockdown PSMB4 could intervene the RIP3 and Mixed lineage kinase domain-like protein (MLKL) pathway in Tumor necrosis factor-α (TNF-α) induced necroptosis cell model. Based on our experimental data, we boldly conclude that PSMB4 is associated with RIP3 involved necroptosis after SCI.Entities:
Keywords: MLKL; Necroptosis; PSMB4; RIP3; SCI; TNF-α
Mesh:
Substances:
Year: 2016 PMID: 27514644 DOI: 10.1007/s11064-016-2033-7
Source DB: PubMed Journal: Neurochem Res ISSN: 0364-3190 Impact factor: 3.996